DUBLIN–(BUSINESS WIRE)–The “Global
Hereditary Angioedema Clinical Trial Pipeline Highlights – 2019”
report has been added to ResearchAndMarkets.com’s
offering.
Hereditary Angioedema Pipeline Highlights – 2019 provides most
up-to-date information on key pipeline products in the global Hereditary
Angioedema market. It covers emerging therapies for Hereditary
Angioedema in active clinical development stages including early and
late stage clinical trials. The pipeline data presented in this report
helps executives for tracking competition, identifying partners,
evaluating opportunities, formulating business development strategies,
and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Hereditary Angioedema pipeline products by clinical
trial stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Hereditary Angioedema pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.
Company:
The report provides Hereditary Angioedema pipeline products by the
company.
Short-term Launch Highlights:
Find out which Hereditary Angioedema pipeline products will be launched
in the US and Ex-US till 2024.
Key Topics Covered:
1. Hereditary Angioedema Pipeline by Stages
2. Hereditary Angioedema Phase 3 Clinical Trial Insights
3. Hereditary Angioedema Phase 2 Clinical Trial Insights
4. Hereditary Angioedema Phase 1 Clinical Trial Insights
5. Hereditary Angioedema Preclinical Research Insights
6. Hereditary Angioedema Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/q5og5j
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs, Clinical
Trials